Cargando…
THU255 Tirzepatide-induced Weight Loss In A Type 2 Diabetic Taking Oral Contraceptives
Disclosure: A. Arunachalam: None. A. Nguyen: None. N.L. Shah: None. Obesity is a global health challenge which can lead to type 2 diabetes, hypertension, cardiovascular disease, and decreased life expectancy. In addition to lifestyle intervention, pharmacotherapy to sustain weight loss has remained...
Autores principales: | Arunachalam, Amar, Nguyen, Andy, Shah, Neel L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555013/ http://dx.doi.org/10.1210/jendso/bvad114.692 |
Ejemplares similares
-
THU296 Effect Of Tirzepatide In GADA-positive Individuals With T2D: A Post Hoc Analysis Of The SURPASS 2-5 Trials
por: Peters, Anne L, et al.
Publicado: (2023) -
THU252 Can An AI Chatbot, ChatGPT, Help Our Patients with Diabetes And Weight Loss?
por: Cheng, Emily, et al.
Publicado: (2023) -
FRI643 Tirzepatide Associated Partial Small Bowel Obstruction: A Case Report
por: Mathew, Anoopa, et al.
Publicado: (2023) -
FRI612 Tirzepatide For The Treatment Of Post-bariatric Surgery Hypoglycemia And Early Dumping Syndrome
por: Frederick Stortz, Ethan, et al.
Publicado: (2023) -
THU272 Early Time Restricted Feeding As a Weight Neutral Approach To Improved Glycemic Variation
por: Nasserifar, Shabnam, et al.
Publicado: (2023)